As the fall of 2025 kicks off, three of our member startups have announced successful fundraising rounds: Juisci, ArcaScience, and Rofim.
Juisci: €5.5 Million
Mission: Making science accessible to all through AI
Founded in 2021 by Robin Roumengas and Dr. David Luu, Juisci has recently raised €5.5 million to expand its AI technology dedicated to scientific publications.
Its SaaS platform transforms complex scientific articles into clear, interactive, and educational content — from simplified summaries to infographics and explanatory videos.
This funding will strengthen R&D, grow the team, and accelerate international expansion, with a strong focus on the U.S. market.
Rofim: €10 Million
Mission: Improving access to healthcare through telemedicine
Medtech startup Rofim has closed a €10 million funding round to further its mission of ensuring equitable access to healthcare for all.
Its hospital telemedicine platform facilitates medical collaboration, streamlines patient journeys, and enables healthcare institutions to better coordinate care — even in remote areas.
The new funds will fuel Rofim’s growth, help expand its teams, and support deployment across Europe, with the ambition of strengthening both access to and quality of care for more patients.
ArcaScience: $7 Million
Mission: Securing and optimizing drug development
Finally, ArcaScience has raised $7 million to accelerate the rollout of its AI platform, which predicts the benefit-risk profile of drug candidates. The goal: to make treatments safer and more effective for patients.
Backed by investors including The Moon Venture, Pléiade Venture, Plug & Play Ventures, Bpifrance, and Akka Technologies, ArcaScience helps laboratories clarify benefit-risk profiles, refine clinical trials, and shorten development timelines.
This round will support product scaling and team expansion to meet the growing demand in the pharmaceutical market.
A Strong and Diverse Ecosystem
These three fundraising rounds illustrate the strength and diversity of the Future4care ecosystem:
Juisci is transforming scientific knowledge to make it accessible and actionable.
Rofim is improving access to care through telemedicine and hospital coordination.
ArcaScience is securing the development of new treatments with AI.
We warmly congratulate the teams at Juisci, Rofim, and ArcaScience for these major milestones that will help them reach their goals!